309 related articles for article (PubMed ID: 12793855)
1. Statins and their role in vascular protection.
Mason JC
Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
4. Statins have beneficial effects on platelet free radical activity and intracellular distribution of GTPases in hyperlipidaemia.
Hamilton PK; Hughes SM; Plumb RD; Devine A; Leahey W; Lyons KS; Johnston D; McVeigh GE
Clin Sci (Lond); 2010 Mar; 118(5):359-66. PubMed ID: 19740072
[TBL] [Abstract][Full Text] [Related]
5. Microcirculation as a target for the anti-inflammatory properties of statins.
Scalia R; Stalker TJ
Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
7. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
8. The effects of statins on endothelium, inflammation and cardioprotection.
Elrod JW; Lefer DJ
Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
[TBL] [Abstract][Full Text] [Related]
9. Potential vascular benefits of statins.
Kinlay S
Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Timely Top Med Cardiovasc Dis; 2007 Apr; 11():E10. PubMed ID: 17473899
[TBL] [Abstract][Full Text] [Related]
11. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
12. Early vascular benefits of statin therapy.
Tsiara S; Elisaf M; Mikhailidis DP
Curr Med Res Opin; 2003; 19(6):540-56. PubMed ID: 14594527
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
14. Statins in heart failure. Beyond the lipid lowering effect.
Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
[TBL] [Abstract][Full Text] [Related]
15. Potential benefit of statins for vascular disease in systemic sclerosis.
Kuwana M
Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504
[TBL] [Abstract][Full Text] [Related]
16. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
17. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
Arnaud C; Mach F
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
[TBL] [Abstract][Full Text] [Related]
19. Statins and endothelial dysfunction.
Larose E; Ganz P
Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.
Chiong JR; Miller AB
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):96-102. PubMed ID: 12228849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
